Patent · US Active

Substituted benzo[f]imidazo[1,2-a]quinoxalines

US10253254B2 · kind B2 · utility

2Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2017
Grant dateApr 9, 2019
Priority date
Expiry dateApr 18, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC09K2211/1018
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure comprises novel Coelenterazine compounds and methods of use, including a simple delivery device for the photoprotein to create effects by their luminous reaction upon contact with surfaces that contain calcium. Calcium is ubiquitous in and on most surfaces and in the environment; it is this unique property of calcium that makes this a novel use of the photoproteins for entertainment. A base coelenterazine structure is depicted below.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.